AIDS Courier (29/09)

Study Examines Efficacy Of Merck Drug Isentress On HIV Reservoirs

Study Examines Efficacy Of Merck Drug On HIV Reservoirs

Patients who added Merck’s HIV drug Isentress to their regular daily HIV drug regimen “fared no better than those who added a placebo to the mix,” as the drug failed to “reduce low-level reservoirs of HIV,” in the body, according to findings presented at the International AIDS Society conference in Cape Town, South Africa, Bloomberg reports.